NCT07669168 Health Ahead Comparative Effectiveness Study
| NCT ID | NCT07669168 |
| Status | Recruiting |
| Phase | — |
| Sponsor | William Brandenburg, MD |
| Condition | Health Services Accessibility |
| Study Type | INTERVENTIONAL |
| Enrollment | 1,000,000 participants |
| Start Date | 2026-06-09 |
| Primary Completion | 2099-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 1,000,000 participants in total. It began in 2026-06-09 with a primary completion date of 2099-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The Health Ahead Comparative Effectiveness Study is a pragmatic, parallel-arm interventional platform that systematically compares successive changes to preventive health screening on the path toward a fully automated screening system deployable in any environment, including the most isolated and resource-limited communities. Each change is isolated as a single variable against current practice, and every comparison is evaluated with a common set of engagement, behavior-change, experience, cost, and longitudinal outcome measures, so results accumulate on a consistent yardstick across the life of the platform. The first comparison evaluates AI-assisted versus human-only interpretation ("reads") of screening data. Subsequent pre-planned comparisons, added by protocol amendment, evaluate static versus interactive personalized report delivery; mobile community versus fixed laboratory screening; and a hybrid medical-droid-plus-human delivery model versus human-only screening.
Eligibility Criteria
Inclusion Criteria: * Age 18 years or older * Willing and able to provide written informed consent, or enrollment with consent of a legally authorized representative * Willing to participate in longitudinal follow-up. Exclusion Criteria: \- Age under 18 years.
Contact & Investigator
William Brandenburg, MD
PRINCIPAL INVESTIGATOR
Longevity Metrics
Frequently Asked Questions
Who can join the NCT07669168 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Health Services Accessibility. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07669168 currently recruiting?
Yes, NCT07669168 is actively recruiting participants. Contact the research team at info@longevitymetrics.org for enrollment information.
Where is the NCT07669168 trial being conducted?
This trial is being conducted at Boulder, United States.
Who is sponsoring the NCT07669168 clinical trial?
NCT07669168 is sponsored by William Brandenburg, MD. The principal investigator is William Brandenburg, MD at Longevity Metrics. The trial plans to enroll 1,000,000 participants.